Edward E Rylander MD
Hospice & Palliative Medicine
Family Medical Care of Tulsa
Join to View Full Profile
7501 South Riverside ParkwayTulsa, OK 74132
Phone+1 918-710-4200
Fax+1 918-403-6331
Dr. Rylander is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Edward Rylander, MD, is a Family Medicine specialist based in Tulsa, OK, with a subspecialty in Hospice & Palliative Medicine. He completed a fellowship in Hospice and Palliative Medicine at the University of California (San Diego) Medical Center and graduated from Oral Roberts University School of Medicine. Dr. Rylander has been an attending physician at In His Image since 1990 and at Oral Roberts University School of Medicine since 1987. His areas of experience include diabetic neuropathy, sacral plexus injury, hospice and palliative medicine, nutrition, and chronic obstructive pulmonary disease. He participated in a clinical trial studying the efficacy of extended-release niacin/lovastatin versus usual care. Dr. Rylander received multiple certifications for CMS Meaningful Use Stages 1 and 2 from various Cerner Corporation platforms between 2012 and 2017.
Education & Training
University of California (San Diego) Medical CenterFellowship, Hospice and Palliative Medicine, 2001 - 2002
City of Faith HospitalFamily Medicine, 1985 - 1988
Oral Roberts University School of MedicineClass of 1985
Certifications & Licensure
OK State Medical License 1986 - 2027
American Board of Family Medicine Family Medicine- American Board of Family Medicine Hospice and Palliative Medicine
Americian Board of Hospice and Palliative MedicinePalliative Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification P2 Sentinel, Cerner Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Practice Partner, eMDs, 2012, 2014-2017
Clinical Trials
- Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care Start of enrollment: 2003 Jul 01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
